• Viewed 10,240 times by 3014 users (Last 30 days)
  • print Created with Sketch. Print
ALA

AROVELLA THERAPEUTICS LIMITED

4.76% ! 8.0¢
Market Cap $95.68M  !

Arovella Therapeutics Limited is a biotechnology company. The Company is focused on... Arovella Therapeutics Limited is a biotechnology company. The Company is focused on developing its invariant natural killer T (iNKT) cell therapy platform from Imperial College London to treat blood cancers and solid tumors. The Company's lead product is ALA-101. ALA-101 is being developed as an allogeneic cell therapy, which means it can be given from a healthy donor to a patient. ALA-101 is a next-generation CAR-iNKT cell therapy that targets CD19+ B cell lymphomas and leukemias. ALA-101 consists of CAR19-iNKT cells that have been modified to produce a Chimeric Antigen Receptor (CAR) that targets CD19. CD19 is an antigen found on the surface of numerous cancer types. The Company is also engaged in expanding solid tumor treatment through its CLDN18.2-targeting technology licensed from Sparx Group. Its iNKT cells also contain an invariant T cell receptor (iTCR) that targets alpha-galactosylceramide (a-GalCer) bound CD1d, another antigen found on the surface of several cancer types.More

Latest Threads

Tag Subject Date Created with Sketch. Comments Created with Sketch. Views Created with Sketch.
ALA 11/09/25 1 475
11/09/25 Last post  DiiDJJ Comments Created with Sketch.  1  Views Created with Sketch.  475 
ALA 05/09/25 2 837
05/09/25 Last post  abitlikeme Comments Created with Sketch.  2  Views Created with Sketch.  837 
ALA
Company Podcast
05/09/25 0 224
Industrials SECTOR NEWS

Amaero’s big move: Exclusive deal, big targets, and a lot on the line

3DA
15 Sep 2025
AMAERO LTD
05/09/25 Last post  richiec Comments Created with Sketch.  0  Views Created with Sketch.  224 
ALA 05/09/25 14 3.6K
05/09/25 Last post  Megabeast5000 Comments Created with Sketch.  14  Views Created with Sketch.  3.6K 
ALA 03/09/25 0 192
03/09/25 Last post  ASX News Comments Created with Sketch.  0  Views Created with Sketch.  192 
ALA
CD19 CAR-NK cell therapy achieved CR
28/08/25 7 2.5K
28/08/25 Last post  Megabeast5000 Comments Created with Sketch.  7  Views Created with Sketch.  2.5K 
ALA 25/08/25 0 191
25/08/25 Last post  ASX News Comments Created with Sketch.  0  Views Created with Sketch.  191 
ALA 25/08/25 0 155
25/08/25 Last post  ASX News Comments Created with Sketch.  0  Views Created with Sketch.  155 

See All Discussions arrow Created with Sketch.

Timeline

2025 ESG Report
11 Sep 10:54
 
S&P DJI Announces September 2025 Quarterly Rebalance
05 Sep 17:08
 
Notification of Date of 2025 AGM
03 Sep 08:23
 
US Patent to be granted for iNKT Cell Therapy Platform
28 Aug 08:28
 
Notice Under Section 708A
25 Aug 09:58
 
Application for quotation of securities - ALA
25 Aug 09:56
 
View More arrow Created with Sketch.
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
Add to My Watchlist
(20min delay)
Last
8.0¢
Change
-0.004(4.76%)
Mkt cap ! $95.68M
Open High Low Value Volume
8.3¢ 8.3¢ 8.0¢ $22.44K 274.1K

Buyers (Bids)

No. Vol. Price($)
5 197985 8.0¢
 

Sellers (Offers)

Price($) Vol. No.
8.1¢ 43665 1
View Market Depth
Last trade - 16.10pm 15/09/2025 (20 minute delay) ?
Last
8.1¢
  Change
-0.004 ( 0.00 %)
Open High Low Volume
8.3¢ 8.3¢ 8.1¢ 70923
Last updated 15.15pm 15/09/2025 ?
ALA (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.